The value of pharmaceuticals--some direction for employers.

Ron Z. Goetzel; Ronald J. Ozminkowski; David C. Schutt

The value of pharmaceuticals--some direction for employers.

Ron Z. Goetzel, Ronald J. Ozminkowski, David C. Schutt

Research output: Contribution to journal › Article › peer-review

Abstract

The costs of drugs keep rising. Are they worth it? Employers should consider value over cost, and make decisions based on diagnostics and research. They should thoroughly examine their organizations' experience to determine high-priority health conditions and do cost-effectiveness studies (using experienced consultants if necessary) that focus on all of the consequences of conditions and indicate the best medical and pharmaceutical therapies to treat them. Doing so should produce both human and financial dividends.

Original language	English (US)
Pages (from-to)	31-35
Number of pages	5
Journal	Employee benefits journal
Volume	27
Issue number	3
State	Published - Sep 2002
Externally published	Yes

ASJC Scopus subject areas

General Medicine

Cite this

@article{837676cf3bca4b9eb5c5425fc096c6df,

title = "The value of pharmaceuticals--some direction for employers.",

abstract = "The costs of drugs keep rising. Are they worth it? Employers should consider value over cost, and make decisions based on diagnostics and research. They should thoroughly examine their organizations' experience to determine high-priority health conditions and do cost-effectiveness studies (using experienced consultants if necessary) that focus on all of the consequences of conditions and indicate the best medical and pharmaceutical therapies to treat them. Doing so should produce both human and financial dividends.",

author = "Goetzel, {Ron Z.} and Ozminkowski, {Ronald J.} and Schutt, {David C.}",

year = "2002",

month = sep,

language = "English (US)",

volume = "27",

pages = "31--35",

journal = "Employee benefits journal",

issn = "0361-4050",

publisher = "International Foundation of Employee Benifit Plans",

number = "3",

}

TY - JOUR

T1 - The value of pharmaceuticals--some direction for employers.

AU - Goetzel, Ron Z.

AU - Ozminkowski, Ronald J.

AU - Schutt, David C.

PY - 2002/9

Y1 - 2002/9

N2 - The costs of drugs keep rising. Are they worth it? Employers should consider value over cost, and make decisions based on diagnostics and research. They should thoroughly examine their organizations' experience to determine high-priority health conditions and do cost-effectiveness studies (using experienced consultants if necessary) that focus on all of the consequences of conditions and indicate the best medical and pharmaceutical therapies to treat them. Doing so should produce both human and financial dividends.

AB - The costs of drugs keep rising. Are they worth it? Employers should consider value over cost, and make decisions based on diagnostics and research. They should thoroughly examine their organizations' experience to determine high-priority health conditions and do cost-effectiveness studies (using experienced consultants if necessary) that focus on all of the consequences of conditions and indicate the best medical and pharmaceutical therapies to treat them. Doing so should produce both human and financial dividends.

UR - http://www.scopus.com/inward/record.url?scp=0036717943&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036717943&partnerID=8YFLogxK

M3 - Article

C2 - 12219561

AN - SCOPUS:0036717943

SN - 0361-4050

VL - 27

SP - 31

EP - 35

JO - Employee benefits journal

JF - Employee benefits journal

IS - 3

ER -

The value of pharmaceuticals--some direction for employers.

Abstract

ASJC Scopus subject areas

Other files and links

Fingerprint

Cite this